EP300 and malignant colon neoplasm: Treatment of colon cancer cells with the isothiazolone-based agent PCAF and the p300 histone acetyltransferase (HAT) co-inhibitors CCT077791 and CCT077792 inhibited histone acetylation and thus prevented colon cancer cell proliferation [104,105].